omega-n-methylarginine has been researched along with bendroflumethiazide in 1 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (bendroflumethiazide) | Trials (bendroflumethiazide) | Recent Studies (post-2010) (bendroflumethiazide) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 667 | 239 | 44 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lim, PO; MacDonald, TM; Tzemos, N | 1 |
1 trial(s) available for omega-n-methylarginine and bendroflumethiazide
Article | Year |
---|---|
Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study.
Topics: Acetylcholine; Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Benzopyrans; Blood Pressure; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Endothelium, Vascular; Ethanolamines; Female; Forearm; Humans; Hypertension; Male; Middle Aged; Nebivolol; Nitroprusside; omega-N-Methylarginine; Vasoconstriction; Vasodilation; Vasodilator Agents | 2001 |